PTC Therapeutics (PTCT) total debt

Total debt · fiscal 2025
$2.71B

PTC Therapeutics (PTCT) carried total debt of $2.71B at the end of fiscal 2025 (December 31, 2025). That is 9.6% higher than the $2.47B of fiscal 2024. Figures as of 18 Nov 2026, 05:19 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$2.71B
Change on fiscal 2024
+9.6%
Growth, 5 years
+54.3% a year
Growth, 10 years
+40.3% a year
Highest on record
$2.71Bfiscal 2025
Lowest on record
$4.88Mfiscal 2012
Fiscal years on record
122012–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

PTC Therapeutics total debt, in more detail

Over the five fiscal years to 2025 total debt grew at a compound 54.3% a year; over ten years the rate was 40.3% a year. Across the 12 fiscal years on record (2012–2025), the highest was $2.71B in fiscal 2025 and the lowest $4.88M in fiscal 2012.

History · 12 fiscal years

Total debt by fiscal year

PTC Therapeutics total debt, year by year

PTC Therapeutics (PTCT) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$2.71B 9.6% up—
2024$2.47B 10.9% up—
2023$2.23B 52.5% up—
2022$1.46B 238.8% up—
2021$431.43M 39.6% up300.0×
2020$309.15M 1.5% down0.6×
2019$313.86M 105.1% up0.5×
2018$153.01M 5.5% up0.4×
2017$144.97M 47.6% up0.9×
2016$98.22M 6.9% up0.8×
2015$91.85M—0.4×
2012$4.88M——

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of PTC Therapeutics and comparable companies
CompanyTotal debtFiscal year
BillionToOne BLLN$108.90M2025
Hims & Hers Health HIMS$1.12B2025
PTC Therapeutics PTCT$2.71B2025
Haemonetics HAE$1.22B2026
Erasca ERAS$47.14M2025
Concentra Group Holdings Parent CON$2.10B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PTCT

PTC Therapeutics, figure by figure

PTC Therapeutics (PTCT) overview: price, valuation and scorecardAll health care companies by market value

PTC Therapeutics total debt: questions and answers

How much debt does PTC Therapeutics have?

PTC Therapeutics (PTCT) carried total debt of $2.71B at the end of fiscal 2025 (December 31, 2025). That is 9.6% higher than the $2.47B of fiscal 2024.

What is the growth rate of PTC Therapeutics's total debt?

Over the five fiscal years to 2025 total debt grew at a compound 54.3% a year; over ten years the rate was 40.3% a year.

What are the highest and lowest total debt figures on record for PTC Therapeutics?

Across the 12 fiscal years on record (2012–2025), the highest was $2.71B in fiscal 2025 and the lowest $4.88M in fiscal 2012.

How is PTC Therapeutics's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “PTC Therapeutics (PTCT) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/PTCT/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.